Moneycontrol
HomeNewsIndiaCoronavirus pandemic | MCX staffer succumbs to COVID-19; nine others test positive
Trending Topics

Coronavirus pandemic | MCX staffer succumbs to COVID-19; nine others test positive

The staffer died on Monday and the nine colleagues who have tested positive were from a team of 30 which used to spend a fortnight at the commodity bourse's office in suburban Andheri by rotation since the lockdown was announced in March, the officials said.

June 06, 2020 / 18:50 IST
Story continues below Advertisement

A 36-year-old staffer of the Multi Commodity Exchange (MCX) has died of COVID-19, while nine others, who were part of a core team which helped ensure business continuity of the bourse during the lockdown, have tested positive for the novel coronavirus, officials said on Saturday.

The staffer died on Monday and the nine colleagues who have tested positive were from a team of 30 which used to spend a fortnight at the commodity bourse's office in suburban Andheri by rotation since the lockdown was announced in March, the officials said.

Story continues below Advertisement

Coronavirus India News LIVE Updates

However, it was still unclear if the office has been sealed and if so, how is the exchange continuing with its operations.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show